Quarterly report · Q2

Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥4.9bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥11.8bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥5.5bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥210m2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥343m2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥203m2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥889m2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥339m2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥79m2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥339m2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥3m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥613m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥249m2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥3m2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥249m2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥7.7bnat 2022-09-30Cons.Assets
Total assets¥8.6bnat 2022-03-31Cons.Assets
Total assets¥8.3bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥5.7bnat 2022-09-30Cons.Liabilities
Total liabilities¥6.6bnat 2022-03-31Cons.Liabilities
Net assets / equity¥2.0bnat 2022-09-30Cons.Net assets
Net assets / equity¥2.0bnat 2022-03-31Cons.Net assets
Net assets / equity¥1.6bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥2.0bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥2.3bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥2.0bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.3bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.0bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.1bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥45m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥291m2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥31m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥151m2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥48m2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥371m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥696m2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥326m2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥1.142022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-32.712022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥228.112021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥92.512021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥40.872021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio26.2%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio23.3%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio19.7%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 37
SegmentItemPeriodValue
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥3.3bn
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥3.3bn
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥5m
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥116m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥752m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥746m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥6m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥70m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥868m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥867m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥1m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥47m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥5.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥4.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥12m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥233m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-09-30−¥103,000
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥3.5bn
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥3.5bn
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥5m
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥173m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥591m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥582m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥8m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥51m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥1.5bn
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥1.5bn
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥12m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥170m
—segment totalrevenue2021-04-01 → 2021-09-30¥5.5bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥5.5bn
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥26m
—segment totalsegment profit2021-04-01 → 2021-09-30¥395m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥5.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥5.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥26m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥395m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 530
ItemContextValueUnit
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember1453000
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.5403
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember500000
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.1859
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember44000
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0163
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember43200
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0160
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember40500
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0150
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember20263
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0075
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember16500
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0061
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember13000
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0048
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember12500
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0046
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember12400
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0046
Number of shares heldCurrentQuarterInstant2155363
Shareholding ratioCurrentQuarterInstant0.8016
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember48900
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember26848
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember2684800
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember4020
Number of shares issued shares voting rightsCurrentQuarterInstant2737720
Number of voting rights issued shares voting rightsCurrentQuarterInstant26848
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member48900
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member48900
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0178
Number of shares held in own name treasury shares etcCurrentQuarterInstant48900
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant48900
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0178
Cash and depositsPrior1YearInstant2339050000JPY
Cash and depositsCurrentQuarterInstant1981990000JPY
Notes and accounts receivable trade and contract assetsPrior1YearInstant1608039000JPY
Notes and accounts receivable trade and contract assetsCurrentQuarterInstant1206923000JPY
Merchandise and finished goodsPrior1YearInstant481833000JPY
Merchandise and finished goodsCurrentQuarterInstant485777000JPY
Other caPrior1YearInstant122430000JPY
Other caCurrentQuarterInstant207368000JPY
Allowance for doubtful accounts caPrior1YearInstant-131000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-115000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass